EMEA (Europe, Middle East and Africa) Dengue Vaccines Market Report 2017

November 2017 | 106 pages | ID: EBD71C65070EN
QYResearch

Abstracts

In this report, the EMEA Dengue Vaccines market is valued at USD XX million in 2016 and is expected to reach USD XX million by the end of 2022, growing at a CAGR of XX% between 2016 and 2022.

Geographically, this report split EMEA into Europe, the Middle East and Africa, With sales (K Pcs), revenue (Million USD), market share and growth rate of Dengue Vaccines for these regions, from 2012 to 2022 (forecast)

• Europe: Germany, France, UK, Russia, Italy and Benelux;
• Middle East: Saudi Arabia, Israel, UAE and Iran;
• Africa: South Africa, Nigeria, Egypt and Algeria.

EMEA Dengue Vaccines market competition by top manufacturers/players, with Dengue Vaccines sales volume (K Pcs), price (USD/Pcs), revenue (Million USD) and market share for each manufacturer/player; the top players including

• Sanofi
• Takeda Pharmaceutical

On the basis of product, this report displays the sales volume, revenue, product price, market share and growth rate of each type, primarily split into

• CYD-TDV
• Tak-003
• Other

On the basis on the end users/applications, this report focuses on the status and outlook for major applications/end users, sales volume, market share and growth rate for each application, including

• Hospitals
• Government Institutes
• Non-Governmental Organizations (NGOs)

If you have any special requirements, please let us know and we will offer you the report as you want.

Contents

EMEA (Europe, Middle East and Africa) Dengue Vaccines Market Report 2017

1 DENGUE VACCINES OVERVIEW

1.1 Product Overview and Scope of Dengue Vaccines
1.2 Classification of Dengue Vaccines
  1.2.1 EMEA Dengue Vaccines Market Size (Sales) Comparison by Type (2012-2022)
  1.2.2 EMEA Dengue Vaccines Market Size (Sales) Market Share by Type (Product Category) in 2016
  1.2.3 CYD-TDV
  1.2.4 Tak-003
  1.2.5 Other
1.3 EMEA Dengue Vaccines Market by Application/End Users
  1.3.1 EMEA Dengue Vaccines Sales (Volume) and Market Share Comparison by Application (2012-2022
  1.3.2 Hospitals
  1.3.3 Government Institutes
  1.3.4 Non-Governmental Organizations (NGOs)
1.4 EMEA Dengue Vaccines Market by Region
  1.4.1 EMEA Dengue Vaccines Market Size (Value) Comparison by Region (2012-2022)
  1.4.2 Europe Status and Prospect (2012-2022)
  1.4.3 Middle East Status and Prospect (2012-2022)
  1.4.4 Africa Status and Prospect (2012-2022)
1.5 EMEA Market Size (Value and Volume) of Dengue Vaccines (2012-2022)
  1.5.1 EMEA Dengue Vaccines Sales and Growth Rate (2012-2022)
  1.5.2 EMEA Dengue Vaccines Revenue and Growth Rate (2012-2022)

2 EMEA DENGUE VACCINES COMPETITION BY MANUFACTURERS/PLAYERS/SUPPLIERS, REGION, TYPE AND APPLICATION

2.1 EMEA Dengue Vaccines Market Competition by Players/Manufacturers
  2.1.1 EMEA Dengue Vaccines Sales Volume and Market Share of Major Players (2012-2017)
  2.1.2 EMEA Dengue Vaccines Revenue and Share by Players (2012-2017)
  2.1.3 EMEA Dengue Vaccines Sale Price by Players (2012-2017)
2.2 EMEA Dengue Vaccines (Volume and Value) by Type/Product Category
  2.2.1 EMEA Dengue Vaccines Sales and Market Share by Type (2012-2017)
  2.2.2 EMEA Dengue Vaccines Revenue and Market Share by Type (2012-2017)
  2.2.3 EMEA Dengue Vaccines Sale Price by Type (2012-2017)
2.3 EMEA Dengue Vaccines (Volume) by Application
2.4 EMEA Dengue Vaccines (Volume and Value) by Region
  2.4.1 EMEA Dengue Vaccines Sales and Market Share by Region (2012-2017)
  2.4.2 EMEA Dengue Vaccines Revenue and Market Share by Region (2012-2017)
  2.4.3 EMEA Dengue Vaccines Sales Price by Region (2012-2017)

3 EUROPE DENGUE VACCINES (VOLUME, VALUE AND SALES PRICE), BY PLAYERS, COUNTRIES, TYPE AND APPLICATION

3.1 Europe Dengue Vaccines Sales and Value (2012-2017)
  3.1.1 Europe Dengue Vaccines Sales Volume and Growth Rate (2012-2017)
  3.1.2 Europe Dengue Vaccines Revenue and Growth Rate (2012-2017)
3.2 Europe Dengue Vaccines Sales and Market Share by Type
3.3 Europe Dengue Vaccines Sales and Market Share by Application
3.4 Europe Dengue Vaccines Sales Volume and Value (Revenue) by Countries
  3.4.1 Europe Dengue Vaccines Sales Volume by Countries (2012-2017)
  3.4.2 Europe Dengue Vaccines Revenue by Countries (2012-2017)
  3.4.3 Germany Dengue Vaccines Sales and Growth Rate (2012-2017)
  3.4.4 France Dengue Vaccines Sales and Growth Rate (2012-2017)
  3.4.5 UK Dengue Vaccines Sales and Growth Rate (2012-2017)
  3.4.6 Russia Dengue Vaccines Sales and Growth Rate (2012-2017)
  3.4.7 Italy Dengue Vaccines Sales and Growth Rate (2012-2017)
  3.4.8 Benelux Dengue Vaccines Sales and Growth Rate (2012-2017)

4 MIDDLE EAST DENGUE VACCINES (VOLUME, VALUE AND SALES PRICE), BY REGION, TYPE AND APPLICATION

4.1 Middle East Dengue Vaccines Sales and Value (2012-2017)
  4.1.1 Middle East Dengue Vaccines Sales Volume and Growth Rate (2012-2017)
  4.1.2 Middle East Dengue Vaccines Revenue and Growth Rate (2012-2017)
4.2 Middle East Dengue Vaccines Sales and Market Share by Type
4.3 Middle East Dengue Vaccines Sales and Market Share by Application
4.4 Middle East Dengue Vaccines Sales Volume and Value (Revenue) by Countries
  4.4.1 Middle East Dengue Vaccines Sales Volume by Countries (2012-2017)
  4.4.2 Middle East Dengue Vaccines Revenue by Countries (2012-2017)
  4.4.3 Saudi Arabia Dengue Vaccines Sales and Growth Rate (2012-2017)
  4.4.4 Israel Dengue Vaccines Sales and Growth Rate (2012-2017)
  4.4.5 UAE Dengue Vaccines Sales and Growth Rate (2012-2017)
  4.4.6 Iran Dengue Vaccines Sales and Growth Rate (2012-2017)

5 AFRICA DENGUE VACCINES (VOLUME, VALUE AND SALES PRICE) BY PLAYERS, COUNTRIES, TYPE AND APPLICATION

5.1 Africa Dengue Vaccines Sales and Value (2012-2017)
  5.1.1 Africa Dengue Vaccines Sales Volume and Growth Rate (2012-2017)
  5.1.2 Africa Dengue Vaccines Revenue and Growth Rate (2012-2017)
5.2 Africa Dengue Vaccines Sales and Market Share by Type
5.3 Africa Dengue Vaccines Sales and Market Share by Application
5.4 Africa Dengue Vaccines Sales Volume and Value (Revenue) by Countries
  5.4.1 Africa Dengue Vaccines Sales Volume by Countries (2012-2017)
  5.4.2 Africa Dengue Vaccines Revenue by Countries (2012-2017)
  5.4.3 South Africa Dengue Vaccines Sales and Growth Rate (2012-2017)
  5.4.4 Nigeria Dengue Vaccines Sales and Growth Rate (2012-2017)
  5.4.5 Egypt Dengue Vaccines Sales and Growth Rate (2012-2017)
  5.4.6 Algeria Dengue Vaccines Sales and Growth Rate (2012-2017)

6 EMEA DENGUE VACCINES MANUFACTURERS/PLAYERS PROFILES AND SALES DATA

6.1 Sanofi
  6.1.1 Company Basic Information, Manufacturing Base and Competitors
  6.1.2 Dengue Vaccines Product Type, Application and Specification
    6.1.2.1 Product A
    6.1.2.2 Product B
  6.1.3 Sanofi Dengue Vaccines Sales, Revenue, Price and Gross Margin (2012-2017)
  6.1.4 Main Business/Business Overview
6.2 Takeda Pharmaceutical
  6.2.1 Company Basic Information, Manufacturing Base and Competitors
  6.2.2 Dengue Vaccines Product Type, Application and Specification
    6.2.2.1 Product A
    6.2.2.2 Product B
  6.2.3 Takeda Pharmaceutical Dengue Vaccines Sales, Revenue, Price and Gross Margin (2012-2017)
  6.2.4 Main Business/Business Overview

7 DENGUE VACCINES MANUFACTURING COST ANALYSIS

7.1 Dengue Vaccines Key Raw Materials Analysis
  7.1.1 Key Raw Materials
  7.1.2 Price Trend of Key Raw Materials
  7.1.3 Key Suppliers of Raw Materials
  7.1.4 Market Concentration Rate of Raw Materials
7.2 Proportion of Manufacturing Cost Structure
  7.2.1 Raw Materials
  7.2.2 Labor Cost
  7.2.3 Manufacturing Expenses
7.3 Manufacturing Process Analysis of Dengue Vaccines

8 INDUSTRIAL CHAIN, SOURCING STRATEGY AND DOWNSTREAM BUYERS

8.1 Dengue Vaccines Industrial Chain Analysis
8.2 Upstream Raw Materials Sourcing
8.3 Raw Materials Sources of Dengue Vaccines Major Manufacturers in 2016
8.4 Downstream Buyers

9 MARKETING STRATEGY ANALYSIS, DISTRIBUTORS/TRADERS

9.1 Marketing Channel
  9.1.1 Direct Marketing
  9.1.2 Indirect Marketing
  9.1.3 Marketing Channel Development Trend
9.2 Market Positioning
  9.2.1 Pricing Strategy
  9.2.2 Brand Strategy
  9.2.3 Target Client
9.3 Distributors/Traders List

10 MARKET EFFECT FACTORS ANALYSIS

10.1 Technology Progress/Risk
  10.1.1 Substitutes Threat
  10.1.2 Technology Progress in Related Industry
10.2 Consumer Needs/Customer Preference Change
10.3 Economic/Political Environmental Change

11 EMEA DENGUE VACCINES MARKET FORECAST (2017-2022)

11.1 EMEA Dengue Vaccines Sales, Revenue and Price Forecast (2017-2022)
  11.1.1 EMEA Dengue Vaccines Sales and Growth Rate Forecast (2017-2022)
  11.1.2 EMEA Dengue Vaccines Revenue and Growth Rate Forecast (2017-2022)
  11.1.3 EMEA Dengue Vaccines Price and Trend Forecast (2017-2022)
11.2 EMEA Dengue Vaccines Sales, Revenue and Growth Rate Forecast by Region (2017-2022)
11.3 Europe Dengue Vaccines Sales, Revenue and Growth Rate Forecast by Region (2017-2022)
11.4 Middle Eastt Dengue Vaccines Sales, Revenue and Growth Rate Forecast by Region (2017-2022)
11.5 Africa Dengue Vaccines Sales, Revenue and Growth Rate Forecast by Region (2017-2022)
11.6 EMEA Dengue Vaccines Sales Forecast by Type (2017-2022)
11.7 EMEA Dengue Vaccines Sales Forecast by Application (2017-2022)

12 RESEARCH FINDINGS AND CONCLUSION

13 APPENDIX

13.1 Methodology/Research Approach
  13.1.1 Research Programs/Design
  13.1.2 Market Size Estimation
  13.1.3 Market Breakdown and Data Triangulation
13.2 Data Source
  13.2.1 Secondary Sources
  13.2.2 Primary Sources
13.3 Disclaimer


The report requires updating with new data and is sent in 2-3 business days after order is placed.

List Of Tables

LIST OF TABLES AND FIGURES

Figure Product Picture of Dengue Vaccines
Figure EMEA Dengue Vaccines Sales Volume (K Pcs) by Type (2012-2022)
Figure EMEA Dengue Vaccines Sales Volume Market Share by Type (Product Category) in 2016
Figure CYD-TDV Product Picture
Figure Tak-003 Product Picture
Figure Other Product Picture
Figure EMEA Dengue Vaccines Sales Volume (K Pcs) by Application (2012-2022)
Figure EMEA Sales Market Share of Dengue Vaccines by Application in 2016
Figure Hospitals Examples
Table Key Downstream Customer in Hospitals
Figure Government Institutes Examples
Table Key Downstream Customer in Government Institutes
Figure Non-Governmental Organizations (NGOs) Examples
Table Key Downstream Customer in Non-Governmental Organizations (NGOs)
Figure EMEA Dengue Vaccines Market Size (Million USD) by Region (2012-2022)
Figure Europe Dengue Vaccines Revenue (Million USD) and Growth Rate (2012-2022)
Figure Europe Dengue Vaccines Revenue (Million USD) Status and Forecast by Countries
Figure Middle East Dengue Vaccines Revenue (Million USD) and Growth Rate (2012-2022)
Figure Middle East Dengue Vaccines Revenue (Million USD) Status and Forecast by Countries
Figure Africa Dengue Vaccines Revenue (Million USD) and Growth Rate (2012-2022)
Figure Africa Dengue Vaccines Revenue (Million USD) Status and Forecast by Countries
Figure EMEA Dengue Vaccines Sales Volume and Growth Rate (2012-2022)
Figure EMEA Dengue Vaccines Revenue (Million USD) and Growth Rate (2012-2022)
Figure EMEA Dengue Vaccines Market Major Players Product Sales Volume (K Pcs) (2012-2017)
Table EMEA Dengue Vaccines Sales Volume (K Pcs) of Major Players (2012-2017)
Table EMEA Dengue Vaccines Sales Share by Players (2012-2017)
Figure 2016 Dengue Vaccines Sales Share by Players
Figure 2017 Dengue Vaccines Sales Share by Players
Figure EMEA Dengue Vaccines Market Major Players Product Revenue (Million USD) (2012-2017)
Table EMEA Dengue Vaccines Revenue (Million USD) by Players (2012-2017)
Table EMEA Dengue Vaccines Revenue Share by Players (2012-2017)
Table 2016 EMEA Dengue Vaccines Revenue Share by Players
Table 2017 EMEA Dengue Vaccines Revenue Share by Players
Table EMEA Dengue Vaccines Sale Price (USD/Pcs) by Players (2012-2017)
Table EMEA Dengue Vaccines Sales (K Pcs) and Market Share by Type (2012-2017)
Table EMEA Dengue Vaccines Sales Share by Type (2012-2017)
Figure Sales Market Share of Dengue Vaccines by Type (2012-2017)
Figure EMEA Dengue Vaccines Sales Market Share by Type (2012-2017)
Table EMEA Dengue Vaccines Revenue (Million USD) and Market Share by Type (2012-2017)
Table EMEA Dengue Vaccines Revenue Share by Type (2012-2017)
Figure Revenue Market Share of Dengue Vaccines by Type in 2016
Table EMEA Dengue Vaccines Sale Price (USD/Pcs) by Type (2012-2017)
Table EMEA Dengue Vaccines Sales (K Pcs) and Market Share by Application (2012-2017)
Table EMEA Dengue Vaccines Sales Share by Application (2012-2017)
Figure Sales Market Share of Dengue Vaccines by Application (2012-2017)
Figure EMEA Dengue Vaccines Sales Market Share by Application in 2016
Table EMEA Dengue Vaccines Sales (K Pcs) and Market Share by Region (2012-2017)
Table EMEA Dengue Vaccines Sales Share by Region (2012-2017)
Figure Sales Market Share of Dengue Vaccines by Region (2012-2017)
Figure EMEA Dengue Vaccines Sales Market Share in 2016
Table EMEA Dengue Vaccines Revenue (Million USD) and Market Share by Region (2012-2017)
Table EMEA Dengue Vaccines Revenue Share by Region (2012-2017)
Figure Revenue Market Share of Dengue Vaccines by Region (2012-2017)
Figure EMEA Dengue Vaccines Revenue Market Share Regions in 2016
Table EMEA Dengue Vaccines Sales Price (USD/Pcs) by Region (2012-2017)
Figure Europe Dengue Vaccines Sales (K Pcs) and Growth Rate (2012-2017)
Figure Europe Dengue Vaccines Revenue and Growth Rate (2012-2017)
Table Europe Dengue Vaccines Sales (K Pcs) by Type (2012-2017)
Table Europe Dengue Vaccines Market Share by Type (2012-2017)
Figure Europe Dengue Vaccines Market Share by Type in 2016
Table Europe Dengue Vaccines Sales (K Pcs) by Application (2012-2017)
Table Europe Dengue Vaccines Market Share by Application (2012-2017)
Figure Europe Dengue Vaccines Market Share by Application in 2016
Table Europe Dengue Vaccines Sales (K Pcs) by Countries (2012-2017)
Table Europe Dengue Vaccines Sales Market Share by Countries (2012-2017)
Figure Europe Dengue Vaccines Sales Market Share by Countries (2012-2017)
Figure Europe Dengue Vaccines Sales Market Share by Countries in 2016
Table Europe Dengue Vaccines Revenue (Million USD) by Countries (2012-2017)
Table Europe Dengue Vaccines Revenue Market Share by Countries (2012-2017)
Figure Europe Dengue Vaccines Revenue Market Share by Countries (2012-2017)
Figure Europe Dengue Vaccines Revenue Market Share by Countries in 2016
Figure Germany Dengue Vaccines Sales (K Pcs) and Growth Rate (2012-2017)
Figure France Dengue Vaccines Sales (K Pcs) and Growth Rate (2012-2017)
Figure UK Dengue Vaccines Sales (K Pcs) and Growth Rate (2012-2017)
Figure Russia Dengue Vaccines Sales (K Pcs) and Growth Rate (2012-2017)
Figure Italy Dengue Vaccines Sales (K Pcs) and Growth Rate (2012-2017)
Figure Benelux Dengue Vaccines Sales (K Pcs) and Growth Rate (2012-2017)
Figure Middle East Dengue Vaccines Sales (K Pcs) and Growth Rate (2012-2017)
Figure Middle East Dengue Vaccines Revenue (Million USD) and Growth Rate (2012-2017)
Table Middle East Dengue Vaccines Sales (K Pcs) by Type (2012-2017)
Table Middle East Dengue Vaccines Market Share by Type (2012-2017)
Figure Middle East Dengue Vaccines Market Share by Type (2012-2017)
Table Middle East Dengue Vaccines Sales (K Pcs) by Applications (2012-2017)
Table Middle East Dengue Vaccines Market Share by Applications (2012-2017)
Figure Middle East Dengue Vaccines Sales Market Share by Application in 2016
Table Middle East Dengue Vaccines Sales Volume (K Pcs) by Countries (2012-2017)
Table Middle East Dengue Vaccines Sales Volume Market Share by Countries (2012-2017)
Figure Middle East Dengue Vaccines Sales Volume Market Share by Countries in 2016
Table Middle East Dengue Vaccines Revenue (Million USD) by Countries (2012-2017)
Table Middle East Dengue Vaccines Revenue Market Share by Countries (2012-2017)
Figure Middle East Dengue Vaccines Revenue Market Share by Countries (2012-2017)
Figure Middle East Dengue Vaccines Revenue Market Share by Countries in 2016
Figure Saudi Arabia Dengue Vaccines Sales (K Pcs) and Growth Rate (2012-2017)
Figure Israel Dengue Vaccines Sales (K Pcs) and Growth Rate (2012-2017)
Figure UAE Dengue Vaccines Sales (K Pcs) and Growth Rate (2012-2017)
Figure Iran Dengue Vaccines Sales (K Pcs) and Growth Rate (2012-2017)
Figure Africa Dengue Vaccines Sales (K Pcs) and Growth Rate (2012-2017)
Figure Africa Dengue Vaccines Revenue (Million USD) and Growth Rate (2012-2017)
Table Africa Dengue Vaccines Sales (K Pcs) by Type (2012-2017)
Table Africa Dengue Vaccines Sales Market Share by Type (2012-2017)
Figure Africa Dengue Vaccines Sales Market Share by Type (2012-2017)
Figure Africa Dengue Vaccines Sales Market Share by Type in 2016
Table Africa Dengue Vaccines Sales (K Pcs) by Application (2012-2017)
Table Africa Dengue Vaccines Sales Market Share by Application (2012-2017)
Figure Africa Dengue Vaccines Sales Market Share by Application (2012-2017)
Table Africa Dengue Vaccines Sales Volume (K Pcs) by Countries (2012-2017)
Table Africa Dengue Vaccines Sales Market Share by Countries (2012-2017)
Figure Africa Dengue Vaccines Sales Market Share by Countries (2012-2017)
Figure Africa Dengue Vaccines Sales Market Share by Countries in 2016
Table Africa Dengue Vaccines Revenue (Million USD) by Countries (2012-2017)
Table Africa Dengue Vaccines Revenue Market Share by Countries (2012-2017)
Figure Africa Dengue Vaccines Revenue Market Share by Countries (2012-2017)
Figure Africa Dengue Vaccines Revenue Market Share by Countries in 2016
Figure South Africa Dengue Vaccines Sales (K Pcs) and Growth Rate (2012-2017)
Figure Nigeria Dengue Vaccines Sales (K Pcs) and Growth Rate (2012-2017)
Figure Egypt Dengue Vaccines Sales (K Pcs) and Growth Rate (2012-2017)
Figure Algeria Dengue Vaccines Sales (K Pcs) and Growth Rate (2012-2017)
Table Sanofi Dengue Vaccines Basic Information List
Table Sanofi Dengue Vaccines Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2012-2017)
Figure Sanofi Dengue Vaccines Sales (K Pcs) and Growth Rate (2012-2017)
Figure Sanofi Dengue Vaccines Sales Market Share in EMEA (2012-2017)
Figure Sanofi Dengue Vaccines Revenue Market Share in EMEA (2012-2017)
Table Takeda Pharmaceutical Dengue Vaccines Basic Information List
Table Takeda Pharmaceutical Dengue Vaccines Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2012-2017)
Figure Takeda Pharmaceutical Dengue Vaccines Sales (K Pcs) and Growth Rate (2012-2017)
Figure Takeda Pharmaceutical Dengue Vaccines Sales Market Share in EMEA (2012-2017)
Figure Takeda Pharmaceutical Dengue Vaccines Revenue Market Share in EMEA (2012-2017)
Table Production Base and Market Concentration Rate of Raw Material
Figure Price Trend of Key Raw Materials
Table Key Suppliers of Raw Materials
Figure Manufacturing Cost Structure of Dengue Vaccines
Figure Manufacturing Process Analysis of Dengue Vaccines
Figure Dengue Vaccines Industrial Chain Analysis
Table Raw Materials Sources of Dengue Vaccines Major Manufacturers in 2016
Table Major Buyers of Dengue Vaccines
Table Distributors/Traders List
Figure EMEA Dengue Vaccines Sales (K Pcs) and Growth Rate Forecast (2017-2022)
Figure EMEA Dengue Vaccines Revenue and Growth Rate Forecast (2017-2022)
Figure EMEA Dengue Vaccines Price (USD/Pcs) and Trend Forecast (2017-2022)
Table EMEA Dengue Vaccines Sales (K Pcs) Forecast by Region (2017-2022)
Figure EMEA Dengue Vaccines Sales Market Share Forecast by Region (2017-2022)
Table EMEA Dengue Vaccines Revenue (Million USD) Forecast by Region (2017-2022)
Figure EMEA Dengue Vaccines Revenue Market Share Forecast by Region (2017-2022)
Table Europe Dengue Vaccines Sales (K Pcs) Forecast by Countries (2017-2022)
Figure Europe Dengue Vaccines Sales Market Share Forecast by Countries (2017-2022)
Table Europe Dengue Vaccines Revenue (Million USD) Forecast by Countries (2017-2022)
Figure Europe Dengue Vaccines Revenue Market Share Forecast by Countries (2017-2022)
Table Middle East Dengue Vaccines Sales (K Pcs) Forecast by Countries (2017-2022)
Figure Middle East Dengue Vaccines Sales Market Share Forecast by Countries (2017-2022)
Table Middle East Dengue Vaccines Revenue (Million USD) Forecast by Countries (2017-2022)
Figure Middle East Dengue Vaccines Revenue Market Share Forecast by Countries (2017-2022)
Table Africa Dengue Vaccines Sales (K Pcs) Forecast by Countries (2017-2022)
Figure Africa Dengue Vaccines Sales Market Share Forecast by Countries (2017-2022)
Table Africa Dengue Vaccines Revenue (Million USD) Forecast by Countries (2017-2022)
Figure Africa Dengue Vaccines Revenue Market Share Forecast by Countries (2017-2022)
Table EMEA Dengue Vaccines Sales (K Pcs) Forecast by Type (2017-2022)
Figure EMEA Dengue Vaccines Sales Market Share Forecast by Type (2017-2022)
Table EMEA Dengue Vaccines Sales (K Pcs) Forecast by Application (2017-2022)
Figure EMEA Dengue Vaccines Sales Market Share Forecast by Application (2017-2022)
Table Research Programs/Design for This Report
Figure Bottom-up and Top-down Approaches for This Report
Figure Data Triangulation
Table Key Data Information from Secondary Sources
Table Key Data Information from Primary Sources